Will Ozempic/GLP-1 Agonists become an issue with a clear partisan divide in the US in the next 5 years?
Santé et médecineOne-Off3aManifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 59.7%
Prévisionnistes
16
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 25 minutes
4 oct. 24, 21:38 UTC1 nov. 29, 06:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Manifold MarketsNobel Prize awarded for Ozempic (or GLP-1 drugs) by 2030?
Manifold MarketsWill a junk/fast food company use engineered additives to mitigate the effects of GLP-1 agonists (Ozempic)?
Manifold MarketsWill GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
Manifold MarketsPandemic in 2026?
KalshiPlague pandemic in 2026?
PolymarketRègles
Richard Hanania posed the question if we'll see a partisan gap around Ozempic: https://x.com/RichardHanania/status/1842283808890175877
- This will resolve YES if during any point in the next 5 years we'll get any data that shows a significant difference in attitude towards Ozempic based on party affiliation.
- The measure of "significant" and how we capture the attitude is somewhat subjective, so I won't be betting in this market.
- If a survey asked a question like "would you ever consider taking Ozempic?", "Is Ozempic an acceptable form of weightloss?" or even "Do you think Ozempic is safe?" (COVID vaccine repeat) and the difference by party is >= 30%, I'd see this as resolved.
- The core is that the topic of Ozempic has to become politicized.
- It does not matter which side feels better/worse about Ozempic.